Naturalendo Tech Co Ltd (168330) - Net Assets
Based on the latest financial reports, Naturalendo Tech Co Ltd (168330) has net assets worth ₩22.92 Billion KRW (≈ $15.53 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩37.61 Billion ≈ $25.49 Million USD) and total liabilities (₩14.69 Billion ≈ $9.96 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 168330 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩22.92 Billion |
| % of Total Assets | 60.94% |
| Annual Growth Rate | -9.73% |
| 5-Year Change | -36.29% |
| 10-Year Change | N/A |
| Growth Volatility | 14.7 |
Naturalendo Tech Co Ltd - Net Assets Trend (2014–2025)
This chart illustrates how Naturalendo Tech Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Naturalendo Tech Co Ltd stock valuation.
Annual Net Assets for Naturalendo Tech Co Ltd (2014–2025)
The table below shows the annual net assets of Naturalendo Tech Co Ltd from 2014 to 2025. Also explore 168330 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩23.25 Billion ≈ $15.75 Million |
-13.47% |
| 2024-12-31 | ₩26.87 Billion ≈ $18.21 Million |
-13.17% |
| 2023-12-31 | ₩30.94 Billion ≈ $20.97 Million |
-15.41% |
| 2022-12-31 | ₩36.58 Billion ≈ $24.79 Million |
+0.25% |
| 2018-12-31 | ₩36.49 Billion ≈ $24.73 Million |
-33.32% |
| 2017-12-31 | ₩54.72 Billion ≈ $37.08 Million |
+15.69% |
| 2016-12-31 | ₩47.30 Billion ≈ $32.05 Million |
-6.27% |
| 2015-12-31 | ₩50.46 Billion ≈ $34.20 Million |
-29.57% |
| 2014-12-31 | ₩71.65 Billion ≈ $48.55 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Naturalendo Tech Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 214.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩76.04 Billion | 317.15% |
| Total Equity | ₩23.98 Billion | 100.00% |
Naturalendo Tech Co Ltd Competitors by Market Cap
The table below lists competitors of Naturalendo Tech Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lion One Metals Limited
V:LIO
|
$49.54 Million |
|
Zegona Communications Plc
LSE:ZEG
|
$49.55 Million |
|
Vanet Gida Sanayi Ic ve Dis Ticaret AS
IS:VANGD
|
$49.55 Million |
|
Alpha Holdings Inc
KQ:117670
|
$49.57 Million |
|
Cords Cable Industries Limited
NSE:CORDSCABLE
|
$49.53 Million |
|
Doxa AB
ST:DOXA
|
$49.53 Million |
|
Gmb Korea
KO:013870
|
$49.50 Million |
|
International Meal Company Alimentação S.A
SA:MEAL3
|
$49.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Naturalendo Tech Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 27,198,669,940 to 23,977,106,010, a change of -3,221,563,930 (-11.8%).
- Net loss of 3,221,563,930 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-3.22 Billion | -13.44% |
| Total Change | ₩- | -11.84% |
Book Value vs Market Value Analysis
This analysis compares Naturalendo Tech Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.05x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.06x to 3.05x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | ₩1122.88 | ₩2315.00 | x |
| 2023-12-31 | ₩984.53 | ₩2315.00 | x |
| 2024-12-31 | ₩861.44 | ₩2315.00 | x |
| 2025-12-31 | ₩759.41 | ₩2315.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Naturalendo Tech Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.44%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -14.49%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.49x
- Recent ROE (-13.44%) is above the historical average (-19.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 28.98% | 16.73% | 1.40x | 1.24x | ₩13.60 Billion |
| 2015 | -30.75% | -34.86% | 0.64x | 1.38x | ₩-20.56 Billion |
| 2016 | -27.86% | -200.99% | 0.08x | 1.82x | ₩-17.91 Billion |
| 2017 | -18.61% | -95.91% | 0.11x | 1.80x | ₩-13.62 Billion |
| 2018 | -58.86% | -218.40% | 0.15x | 1.85x | ₩-22.81 Billion |
| 2022 | -28.44% | -72.28% | 0.35x | 1.12x | ₩-13.63 Billion |
| 2023 | -14.05% | -23.25% | 0.51x | 1.20x | ₩-7.48 Billion |
| 2024 | -14.29% | -17.46% | 0.67x | 1.23x | ₩-6.61 Billion |
| 2025 | -13.44% | -14.49% | 0.62x | 1.49x | ₩-5.62 Billion |
Industry Comparison
This section compares Naturalendo Tech Co Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $301,287,260,329
- Average return on equity (ROE) among peers: -18.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Naturalendo Tech Co Ltd (168330) | ₩22.92 Billion | 28.98% | 0.64x | $49.53 Million |
| ORIENTBIO Inc. (002630) | $79.92 Billion | -17.35% | 1.38x | $73.37 Million |
| Green Cross (005250) | $221.73 Billion | 2.76% | 8.07x | $293.85 Million |
| Green Cross Holdings Preference Shares (005257) | $1.88 Trillion | -2.88% | 0.99x | $2.92 Million |
| Pharmicell (005690) | $55.99 Billion | -70.00% | 0.14x | $441.61 Million |
| GeneOne Life Science Inc (011000) | $39.44 Billion | 3.58% | 0.21x | $32.81 Million |
| HLB Co. Ltd (028300) | $582.25 Billion | -32.21% | 0.29x | $2.92 Billion |
| Mgenplus Co. Ltd. (032790) | $10.14 Billion | -54.19% | 2.17x | $20.92 Million |
| Daesung Microbiological Labs. Co. Ltd (036480) | $36.31 Billion | 4.18% | 0.71x | $15.73 Million |
| Seoulin Bioscience Co.Ltd (038070) | $83.06 Billion | -0.14% | 0.37x | $24.29 Million |
| Hyundai Bioscience Co. Ltd (048410) | $22.49 Billion | -13.82% | 0.46x | $419.86 Million |
About Naturalendo Tech Co Ltd
Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Staun… Read more